DuPont Nutrition Biosciences ApS has obtained a novel food authorization for lactitol.
Lactitol complying with the specifications may be placed on the market in the EU as a novel food ingredient to be used in food supplements in capsule or tablet form intended for the adult population with a maximum dose of 20 g lactitol per day.
Lactitol was already authorized as a food additive (for sweetening or other technological purposes) in several foods, including food supplements supplied in solid and syrup form. The novel food authorization now allows the use for a nutritional/physiological purpose.
Other food businesses may use lactitol obtained from Dupont or they may apply for their own authorization if they can demonstrate that their lactitol is substantially equivalent to the authorized ingredient. This will not be necessary anymore as of January 1, 2018, when all authorized novel foods are expected to be included in the generic Union list.